Literature DB >> 26777117

Dopamine D2 receptors are involved in the regulation of Fyn and metabotropic glutamate receptor 5 phosphorylation in the rat striatum in vivo.

Li-Min Mao1, John Q Wang1,2.   

Abstract

Fyn, a major Src family kinase (SFK) member that is densely expressed in striatal neurons, is actively involved in the regulation of cellular and synaptic activities in local neurons. This SFK member is likely regulated by dopamine signaling through a receptor mechanism involving dopamine D2 receptors (D2Rs). This study characterizes the D2R-dependent regulation of Fyn in the rat striatum in vivo. Moreover, we explore whether D2Rs regulate metabotropic glutamate receptor 5 (mGluR5) in its tyrosine phosphorylation and whether the D2R-SFK pathway modulates trafficking of mGluR5. We found that blockade of D2Rs by systemic administration of a D2R antagonist, eticlopride, substantially increased SFK phosphorylation in the striatum. This increase was a transient and reversible event. The eticlopride-induced SFK phosphorylation occurred predominantly in immunopurified Fyn but not in another SFK member, Src. Eticlopride also elevated tyrosine phosphorylation of mGluR5. In parallel, eticlopride enhanced synaptic delivery of active Fyn and mGluR5. Pretreatment with an SFK inhibitor blocked the eticlopride-induced tyrosine phosphorylation and synaptic trafficking of mGluR5. These results indicate that D2Rs inhibit SFK (mainly Fyn) phosphorylation in the striatum. D2Rs also inhibit tyrosine phosphorylation and synaptic recruitment of mGluR5 through a signaling mechanism likely involving Fyn.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  PP2; RRID:AB_10013641; RRID:AB_2106047; RRID:AB_2106058; RRID:AB_303714; RRID:AB_305042; RRID:AB_310119; RRID:AB_397423; RRID:AB_476693; RRID:AB_570921; RRID:AB_627642; RRID:AB_631528; RRID:nif-0000-30467; SFK; Src; eticlopride; metabotropic glutamate receptor; nonreceptor tyrosine kinase; nucleus accumbens; tyrosine phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 26777117      PMCID: PMC4744551          DOI: 10.1002/jnr.23713

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  34 in total

1.  Interactions between Src family protein tyrosine kinases and PSD-95.

Authors:  Lorraine V Kalia; Michael W Salter
Journal:  Neuropharmacology       Date:  2003-11       Impact factor: 5.250

Review 2.  Fyn kinase in brain diseases and cancer: the search for inhibitors.

Authors:  S Schenone; C Brullo; F Musumeci; M Biava; F Falchi; M Botta
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 3.  Src kinase regulation by phosphorylation and dephosphorylation.

Authors:  Robert Roskoski
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

4.  A reduced number of metabotropic glutamate subtype 5 receptors are associated with constitutive homer proteins in a mouse model of fragile X syndrome.

Authors:  Raffaella Giuffrida; Sebastiano Musumeci; Simona D'Antoni; Carmela Maria Bonaccorso; Anna Maria Giuffrida-Stella; Ben A Oostra; Maria Vincenza Catania
Journal:  J Neurosci       Date:  2005-09-28       Impact factor: 6.167

5.  Fyn is required for haloperidol-induced catalepsy in mice.

Authors:  Kotaro Hattori; Shigeo Uchino; Tomoko Isosaka; Mamiko Maekawa; Masaomi Iyo; Toshio Sato; Shinichi Kohsaka; Takeshi Yagi; Shigeki Yuasa
Journal:  J Biol Chem       Date:  2006-01-10       Impact factor: 5.157

6.  Striatal-enriched protein tyrosine phosphatase regulates the PTPα/Fyn signaling pathway.

Authors:  Jian Xu; Pradeep Kurup; Ethan Foscue; Paul J Lombroso
Journal:  J Neurochem       Date:  2015-05-25       Impact factor: 5.372

7.  Differential effects of D1 and D2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced up-regulation of zif/268 mRNA expression in rat forebrain.

Authors:  J Q Wang; J F McGinty
Journal:  J Neurochem       Date:  1995-12       Impact factor: 5.372

8.  Phosphorylation and feedback regulation of metabotropic glutamate receptor 1 by calcium/calmodulin-dependent protein kinase II.

Authors:  Dao-Zhong Jin; Ming-Lei Guo; Bing Xue; Eugene E Fibuch; Eun Sang Choe; Li-Min Mao; John Q Wang
Journal:  J Neurosci       Date:  2013-02-20       Impact factor: 6.167

Review 9.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

10.  Tyrosine phosphorylation of the metabotropic glutamate receptor mGluR5 in striatal neurons.

Authors:  L R Orlando; A W Dunah; D G Standaert; A B Young
Journal:  Neuropharmacology       Date:  2002-08       Impact factor: 5.250

View more
  11 in total

1.  The Kinase Fyn As a Novel Intermediate in L-DOPA-Induced Dyskinesia in Parkinson's Disease.

Authors:  Sara Sanz-Blasco; Melina P Bordone; Ana Damianich; Gimena Gomez; M Alejandra Bernardi; Luciana Isaja; Irene R Taravini; Diane P Hanger; M Elena Avale; Oscar S Gershanik; Juan E Ferrario
Journal:  Mol Neurobiol       Date:  2017-08-24       Impact factor: 5.590

2.  Muscarinic Acetylcholine Receptors Inhibit Fyn Activity in the Rat Striatum In Vivo.

Authors:  Li-Min Mao; Hunter J Faris; John Q Wang
Journal:  J Mol Neurosci       Date:  2018-03-12       Impact factor: 3.444

3.  Antagonism of Dopamine D2 Receptors Alters Phosphorylation of Fyn in the Rat Medial Prefrontal Cortex.

Authors:  Li-Min Mao; John Q Wang
Journal:  J Mol Neurosci       Date:  2017-02-07       Impact factor: 3.444

4.  Effects of the Fyn kinase inhibitor saracatinib on ventral striatal activity during performance of an fMRI monetary incentive delay task in individuals family history positive or negative for alcohol use disorder. A pilot randomised trial.

Authors:  Krishna T Patel; Michael C Stevens; Amanda Dunlap; Alana Gallagher; Stephanie S O'Malley; Kelly DeMartini; Marc N Potenza; John H Krystal; Godfrey D Pearlson
Journal:  Neuropsychopharmacology       Date:  2021-09-02       Impact factor: 8.294

5.  Upregulation of Src Family Tyrosine Kinases in the Rat Striatum by Adenosine A2A Receptors.

Authors:  Li-Min Mao; Shannon Demehri; John Q Wang
Journal:  J Mol Neurosci       Date:  2022-01-18       Impact factor: 2.866

6.  Weighted Burden Analysis of Exome-Sequenced Case-Control Sample Implicates Synaptic Genes in Schizophrenia Aetiology.

Authors:  David Curtis; Leda Coelewij; Shou-Hwa Liu; Jack Humphrey; Richard Mott
Journal:  Behav Genet       Date:  2018-03-21       Impact factor: 2.805

7.  Metabotropic Glutamate Receptor 5 in the Medial Prefrontal Cortex as a Molecular Determinant of Pain and Ensuing Depression.

Authors:  Geehoon Chung; Sang Jeong Kim; Sun Kwang Kim
Journal:  Front Mol Neurosci       Date:  2018-10-08       Impact factor: 5.639

8.  Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors.

Authors:  Giulio Poli; Margherita Lapillo; Carlotta Granchi; Jessica Caciolla; Nayla Mouawad; Isabella Caligiuri; Flavio Rizzolio; Thierry Langer; Filippo Minutolo; Tiziano Tuccinardi
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 9.  Group I Metabotropic Glutamate Receptors and Interacting Partners: An Update.

Authors:  Li-Min Mao; Alaya Bodepudi; Xiang-Ping Chu; John Q Wang
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

10.  Roles of adenosine A1 receptors in the regulation of SFK activity in the rat forebrain.

Authors:  Li-Min Mao; John Q Wang
Journal:  Brain Behav       Date:  2021-06-22       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.